Rowan Stringer

7PUBLICATIONS
47CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 28, 2026
DMPK Considerations for the Development of Covalent Drugs: Insights from an IQ Assessment.

|Dec 23, 2024
Thiazole-Based IL-17 Inhibitors Discovered by Scaffold Morphing.

Juraj Velcicky, Estelle Ngo, Matthias R Bauer

|Sep 14, 2024
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors.

Juraj Velcicky, Matthias R Bauer, Achim Schlapbach

|Jul 17, 2024
Predicting the Intravenous Pharmacokinetics of Covalent Drugs in Animals and Humans.

Rowan Stringer, Tobias Kaster

|May 10, 2023
Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study.

Quentin M Anstee, Kathryn J Lucas, Sven Francque

|Nov 18, 2022
JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRASG12C for the Treatment of Solid Tumors.

Edwige Lorthiois, Marc Gerspacher, Kim S Beyer

Pageof 2

Frequent Collaborators

2 joint publications

Kim S Beyer

2 joint publications

Claudio Bomio-Confaglia

2 joint publications

Juraj Velcicky

2 joint publications

Simona Cotesta